It may never get this far. NP's comment about slowing down is from a man who's worked long hours for years and getting heat from investors for most of it. (Some is self inflicted and justified, some not).

I really think he will strongly consider buyouts of the company(not just a single indication) once the NASH, mTNBC, or HIV monotherapy are proven in multiple patient trials and FDA approval is all but imminent...BP's will be knocking down their door for a piece of the pie and thats NP's way out to let whatever big pharma takes over have the reigns.

That is my speculation. Getting CYDY to full value and shareholders rewarded might be his swan song and going out on top(assuming this all comes to fruition as the ducks seem to be lining up).